---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-039183"
form_type: "8-K"
ticker: "ENVB"
cik: "0000890821"
company_name: "Enveric Biosciences, Inc."
filed_at: "2023-11-02T23:59:59+00:00"
generated_at: "2026-06-09T01:28:56.456345+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Enveric stockholders approve amended 2020 LTIP and share issuance to Lincoln Park Capital

## Summary
- Stockholders approved amendment to 2020 LTIP, increasing authorized shares by 38,259 to 350,000.
- Amendments remove evergreen auto-increase provision and add one-year minimum vesting.
- Issuance of common stock to Lincoln Park Capital Fund approved under Nasdaq Listing Rules 5635(a), (b), (d).
- All five director nominees elected; say-on-pay and ratification of Marcum LLP as auditor passed.
- Annual meeting turnout: 1,074,661 shares (49.3% of outstanding) constituted quorum.

## SEC filing metadata
- accession: 0001493152-23-039183
- form_type: 8-K
- ticker: ENVB
- cik: 0000890821
- company_name: Enveric Biosciences, Inc.
- filed_at: 2023-11-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/890821/000149315223039183/0001493152-23-039183-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/890821/000149315223039183/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-039183
- JSON: https://secwatch.observer/filing/0001493152-23-039183.json
- Plain text: https://secwatch.observer/filing/0001493152-23-039183.txt

## Key facts
- Shareholder Votes
  Enveric Biosciences, Inc. shareholders approved Non-binding advisory vote to approve the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. at the 2023-11-02 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-11-02
  source text: Non-binding advisory vote to approve the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/890821/000149315223039183/0001493152-23-039183-index.htm
- Shareholder Votes
  Enveric Biosciences, Inc. shareholders approved Approval of proposed amendments to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan, as amended. at the 2023-11-02 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-11-02
  source text: Approval of proposed amendments to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan, as amended.
  evidence_url: https://www.sec.gov/Archives/edgar/data/890821/000149315223039183/0001493152-23-039183-index.htm
- Shareholder Votes
  Enveric Biosciences, Inc. shareholders approved Ratification of the appointment of Marcum LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023. at the 2023-11-02 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-11-02
  source text: Ratification of the appointment of Marcum LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/890821/000149315223039183/0001493152-23-039183-index.htm
- Shareholder Votes
  Enveric Biosciences, Inc. shareholders approved Approval of the issuance of shares of common stock to Lincoln Park Capital Fund, LLC pursuant to Nasdaq Listing Rules 5635(a), 5635(b) and 5635(d). at the 2023-11-02 meeting.
  - Outcome: passed
  - Meeting: 2023-11-02
  source text: Approval of the issuance of shares of common stock to Lincoln Park Capital Fund, LLC pursuant to Nasdaq Listing Rules 5635(a), 5635(b) and 5635(d).
  evidence_url: https://www.sec.gov/Archives/edgar/data/890821/000149315223039183/0001493152-23-039183-index.htm
- Shareholder Votes
  Enveric Biosciences, Inc. shareholders approved Election of five directors, to serve until the Company's 2024 annual meeting of stockholders or until their successors are duly elected and qualified. at the 2023-11-02 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-11-02
  source text: On November 2, 2023, the Company held its 2023 Annual Meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/890821/000149315223039183/0001493152-23-039183-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.